Skip to main content

Table 1 Motor Deficit Score (MDS) of the sham, control and treatment groups

From: The attenuation of neurological injury from the use of simvastatin after spinal cord ischemia-reperfusion injury in rats

Time after reperfusion

Group S

(n = 10)

Group A

(n = 10)

Group B

(n = 10)

Group C

(n = 10)

Group D

(n = 10)

P value

8 h

0 (0) ¶

3.5 (1.0)

3.0 (1.0)

3.0 (1.0)

3.0 (1.0)

<  0.001

1 day

0 (0) ¶

3.0 (1.0)

3.5 (1.0)

4.0 (1.0)

3.0 (0)*

<  0.001

3 day

0 (0) ¶

4.0 (1.0)

4.0 (1.0)

4.0 (1.0)

2.5 (1.0)* † ‡

<  0.001

5 day

0 (0) ¶

4.0 (1.0)

4.0 (1.0)

4.0 (1.0)

2.5 (1.0)* † ‡

<  0.001

7 day

0 (0) ¶

3.5 (1.0)

4.0 (1.0)

4.0 (1.0)

2.0 (1.0)* † ‡

<  0.001

  1. 0 = normal; 1 = the animal walks normally, but legs are weak, and the animal cannot pull the legs if they are held by the examiner; 2 = the animal assumes normal body posture on a flat surface and is able to walk, but there is ataxia or spasticity; 3 = the animal is able to walk on its knuckles, or able to walk on the feet without proper stepping; 4 = the animal drags its legs, but there is movement at the knees; and 5 = the animal drags legs without significant movements in the lower limbs and either spasticity or flaccidity is present. Data are presented as median (IQR). Group S: sham group; Group A: control group; Group B: 0.5 mg/kg simvastatin group; Group C: 1 mg/ kg simvastatin group; Group D: 10 mg/kg simvastatin group
  2. ¶: P < 0.001 compared with Group A,B, C and D; *: P < 0.0125 compared with Group C; †: P < 0.0125 compared with Group B; ‡: P < 0.0125 compared with Group A;